Xenter develops an integrated TechMed platform that combines diagnostic evaluation, wireless medical devices and an AI-enabled Physical Intelligence layer that captures high-fidelity clinical data over its XenFi wireless ecosystem. The company is introducing a diagnostics business unit and plans the clinical testing of its Guru dual sensor physiology guidewire in Transcatheter Aortic Valve Replacement procedures. Xenter says the platform grows with every procedure, expanding a library of clinical, procedural and diagnostic data to inform future innovations. The company was founded in 2020 and is headquartered in Draper, Utah. With the close of a $58.25 million Series B, Xenter is funding its commercial launch, continued product development, manufacturing scale-up, and clinical and regulatory programs.

Total raised

$70M

Funding rounds

2

Latest round

Series B

Latest activity

Jul 2026